Non-fasting lipids and risk of cardiovascular disease in patients with diabetes mellitus

[1]  D. Grobbee,et al.  Cohort profile: the EPIC-NL study. , 2010, International journal of epidemiology.

[2]  D. van der A,et al.  Ascertainment and verification of diabetes in the EPIC-NL study. , 2010, The Netherlands journal of medicine.

[3]  B. Nordestgaard,et al.  Fasting and Nonfasting Lipid Levels: Influence of Normal Food Intake on Lipids, Lipoproteins, Apolipoproteins, and Cardiovascular Risk Prediction , 2008, Circulation.

[4]  Samia Mora,et al.  Fasting Compared With Nonfasting Lipids and Apolipoproteins for Predicting Incident Cardiovascular Events , 2008, Circulation.

[5]  B. Nordestgaard,et al.  Nonfasting triglycerides and risk of myocardial infarction, ischemic heart disease, and death in men and women. , 2007, JAMA.

[6]  L. Eberly,et al.  Relation of triglyceride levels, fasting and nonfasting, to fatal and nonfatal coronary heart disease. , 2003, Archives of internal medicine.

[7]  C. Brotons,et al.  New European guidelines on cardiovascular disease prevention in clinical practice , 2003, The European journal of general practice.

[8]  R. Holman,et al.  The UKPDS risk engine: a model for the risk of coronary heart disease in Type II diabetes (UKPDS 56). , 2001, Clinical science.

[9]  H. Boeing,et al.  EPIC-Germany – A Source for Studies into Diet and Risk of Chronic Diseases , 1999, Annals of Nutrition and Metabolism.

[10]  G. Reaven,et al.  Differences in postprandial lipemia between patients with normal glucose tolerance and noninsulin-dependent diabetes mellitus. , 1993, The Journal of clinical endocrinology and metabolism.